Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Alkermes, a pharmaceutical company, has announced the efficacy and safety data of Vivitrol in treating opioid dependence, following opioid detoxification.
Subscribe to our email newsletter
Vivitrol is a once-monthly, extended-release injectable naltrexone medication, used to treat alcohol dependence and opioid dependence.
As measured by the number of opioid-free urine screens, Vivitrol along with psychosocial treatment, reported prolonged efficacy and safety in a one-year, open-label extension of the six-month pivotal study.
The study also measured opioid craving, improvements in quality of life measures, self-reported opioid use and incidence of physical opioid dependence.